JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.

Jilin Aodong Pharmaceutical Group Co., Ltd.

000623

CNE000000719

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
14.85 ^CNY	-1.39%		-0.93%	-1.92%

Apr. 29	Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%	MT

Jilin Aodong Medicine Industry Group Co., Ltd Appoints Han Bo and Sun Maocheng as Independent Directors

July 17, 2014 at 09:47 am EDT

Jilin Aodong Medicine Industry Group Co. Ltd. approved the election of Han Bo and Sun Maocheng as independent directors of the company at the EGM held on 16 July 2014.

Latest news about Jilin Aodong Pharmaceutical Group Co., Ltd.

Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%	Apr. 16	MT
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	Nov. 17	CI
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 21, 2023, has closed with 9,015,780 shares, representing 0.8% for CNY 150 million.	Nov. 16	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Chinese listed firms used endangered animal parts as ingredients -report	23-10-23	RE
Three listed Chinese firms used endangered animal parts as ingredients- report	23-10-22	RE
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	23-10-09	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	23-09-20	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.	23-09-19	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	23-09-03	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd.	23-08-29	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director	23-07-18	CI
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets	23-07-05	MT
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023	23-06-29	CI
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022	23-05-16	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.	23-04-27	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces the Profit Distribution Proposal for 2022	23-04-19	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.	23-04-03	CI
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.	23-01-03	CI
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI

Chart Jilin Aodong Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Jilin Aodong Pharmaceutical Group Co., Ltd.

More charts

Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows: - sale of pharmaceutical products (89.4%); - sale of food products (6.8%); - other (3.8%). All sales are in China.

Sector

Pharmaceuticals

Calendar

2024-05-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Jilin Aodong Pharmaceutical Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.85 CNY

Average target price

22.67 CNY

Spread / Average Target

+52.66%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.	-1.92%	2.49B
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.79%	364B
MERCK & CO., INC.	+20.37%	326B
ABBVIE INC.	+5.52%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+11.05%	167B
PFIZER, INC.	-0.09%	161B

Other Pharmaceuticals

Jilin Aodong Pharmaceutical Group Co., Ltd.

Equities

000623

CNE000000719

Pharmaceuticals

Jilin Aodong Medicine Industry Group Co., Ltd Appoints Han Bo and Sun Maocheng as Independent Directors

Latest news about Jilin Aodong Pharmaceutical Group Co., Ltd.

Chart Jilin Aodong Pharmaceutical Group Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Jilin Aodong Pharmaceutical Group Co., Ltd.

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals